Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost.
第一作者:
Matthias,Moll
第一单位:
Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. Matthias.moll@meduniwien.ac.at.;Center for Medical Data Science, Medical University of Vienna, Vienna, Austria. Matthias.moll@meduniwien.ac.at.
作者:
主题词
人类(Humans);男(雄)性(Male);前列腺肿瘤(Prostatic Neoplasms);近距离放射疗法(Brachytherapy);老年人(Aged);回顾性研究(Retrospective Studies);中年人(Middle Aged);雄激素拮抗药(Androgen Antagonists);放射治疗剂量(Radiotherapy Dosage);前列腺特异抗原(Prostate-Specific Antigen);老年人, 80以上(Aged, 80 and over)
DOI
10.1007/s00066-024-02245-3
PMID
38829436
发布时间
2025-01-19
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文